The latest from @smbmathbiology.bsky.social #BiologyInNumbers: @math.onco's own Ranjini Bhattacharya, working with Joel Brown to study the role of #tumor cell-cell interactions in the context of #metabolism with #TheoreticalBiology #MathOnco [β¦]
The latest from @smbmathbiology.bsky.social #BiologyInNumbers: @math.onco's own Ranjini Bhattacharya, working with Joel Brown to study the role of #tumor cell-cell interactions in the context of #metabolism with #TheoreticalBiology #MathOnco [β¦]
For more on our lab's philosophy and approach to science, check out our @mathonco.bsky.social blog post here: mathematical-oncology.org/blog/bukkuri...
The usual recap of the previous year in blog posts...in the form if a blog post:
mathematical-oncology.org/blog/recap-2...
#MathOnco #2025 #blog #AI #MechanisticLearning #Education #Evolution #Cancer
I am working on my 'recap of 2025' post for the @mathonco.bsky.social blog and found that many of last year's posts had to do with #AI in one form or the other. In this #BiologyInNumbers podcast, @smbmathbiology.bsky.social president Laubenbacher talks about the promises and challenges for us
PhD students from @moffittnews.bsky.social @mathonco.bsky.social presenting their rotation projects and I am amazed about how much a smart person can do in such a short period of time! Featuring Julia Pelesko, Andree Kolliegbo and Cole Saborio
Started a Wikipedia page for fitness seascapes! Please consider adding to it and sharing its existence, itβs just a start!
en.wikipedia.org/wiki/Fitness...
@cbo.bsky.social @carlzimmer.com
@sandyanderson.bsky.social @cancerevo.org @mathonco.bsky.social @arvidagren.bsky.social
Just a few more days to apply to the fully-funded #PhD program in #MathOnco at @moffittnews.bsky.social . Deadline is December 1st!
www.moffitt.org/education/re...
Just going around some of the groups working at the @moffittnews.bsky.social @mathonco.bsky.social #MoffittIMO 2025 and the energy is palpable! I think the judges on Friday morning are going to be blown away by the ideas these guys are working on!
Day 3: Trying to keep the momentum! Subgroup tasks ongoing! @mathonco.bsky.social @moffittnews.bsky.social @sandyanderson.bsky.social
Dr Mansilla-Soto giving #TeamBlue a 10-min crash course in #immunology ! @mathonco.bsky.social @sandyanderson.bsky.social @moffittnews.bsky.social
Day 1: Say hi to #TeamBlue! Preliminary discussions on-going. Cheers to our team leads: Renee Brady-Nicholls,PhD, Jorge Mansilla-Soto,PhD and Nicholas Champion, MD
@mathonco.bsky.social @moffittnews.bsky.social
Speed dating..but for scientists! - - -> IMO version! π @mathonco.bsky.social
Welcome session ongoing with @sandyanderson.bsky.social giving us the history of the famous IMO Workshop @mathonco.bsky.social from year 1 to 12!
Last speaker at #MathOnco25 is our own @mathonco.bsky.social Jeffrey West that provides a study of the #mathonco literature to produce this definition of MathOnco: the use of interpretable models to understand and improve cancer therapy
Well, #IMO retreat is underway now and here is our very own
@sandyanderson.bsky.social
describing some of the changes and accomplishments at
@mathonco.bsky.social
since our last retreat in 2018
#Antifragility in #cancer #treatments one step closer to clinical reality. By Jeff West writing on his #MathOnco research with @andriy-marusyk.bsky.social @sandyanderson.bsky.social et al
Excited to announce that registration for the 13th
@mathonco.bsky.social workshop on Treatment Revolution is now open. Held onsite @moffittnews.bsky.social Nov 2-Nov 7 #MoffittIMO more details: imo13.eventbrite.com. Deluxe travel awards are available on a competitive basis, apply by 10/03!
Lots of great research from the #blackboard to the #bedside at @mathonco.bsky.social
Interested in doing a PhD in #MatOnco next year? Our department at @moffittnews.bsky.social is a great place to do research and we offer fully-paid tuition and fees. Apply before the deadline 12/1 at Moffitt.org/CancerPhD
Then our very own Jill Gallaher discusses our ongoing @evoltherapy.bsky.social clinical trial with @genentech.bsky.social on, Adaptive therapy in advanced basal cell carcinoma driven by imaging and predictive mathematical. #AndersonLab @mathonco.bsky.social @moffittnews.bsky.social
Probably not standard in many PhD courses (that should change!) but our @moffittnews.bsky.social @mathonco.bsky.social students had a lecture on science communication and outreach by the one and only @parmvir.com @scientistsinc.org
Evolutionary theory tells us that to cure #ovariancancer we need to target it when its most vulnerable β at the end of 1st-line tx. The challenge: thatβs also when treatment-induced toxicity is greatest.
Check out our new #IMO12 pre-print with 3 ideas how to tackle this! @mathonco.bsky.social
We had the pleasure of hosting a high school student as part of @mathonco.bsky.social @moffittnews.bsky.social HIP-IMO program led by Dr Renee Brady
www.moffitt.org/education/re...
Really excited to share our new @cellpress.bsky.social Cell paper with @fertiglab.bsky.social and colleagues. 1/n
www.cell.com/cell/fulltex...
@jktgfoundation.bsky.social @itcrtraining.bsky.social @smbmathbiology.bsky.social #mathbio #mathonco @mathonco.bsky.social @deniswirtz.bsky.social
Submit your abstract for #MathOnco25 in Tampa this October!
In this week's post Jesse Kreger (@adamlmaclean.bsky.socialβ¬) discusses his latest work in #cancer #systems #immunology together with Edgar Gonzalez to study the mechanisms of response of breast cancer to #checkPointInhibitors
It was a great meeting and made me more optimistic about the role of AI in #MathOnco research
Yesterday's #mathonco minisymp with @mathonco.bsky.social @moffittnews.bsky.social's chair and friend @sandyanderson.bsky.social presenting models that capture patient data and help us to understand how to improve treatment schedules in a clinically translatable way
Former HAL developer and @mathonco.bsky.social student, Rafael Bravo now with @utaustin.bsky.social presents new work on: "Testing the feasibility of estimating the migration to proliferation rate ratio in glioblastoma from single time-point MRI data" #SMB2025
Next up is our very own @mathonco.bsky.social faculty @rejniaklab.bsky.social presenting, "Using tumor histology to analyze cancer immunotherapies with the agent-based micropharamacology model" #SMB2025 @moffittnews.bsky.social